These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38206304)

  • 1. Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
    Liu B; Xu Y; Hu B; Song X; Lin S; Wang J; Wang L; Chu T; Peng T; Xu M; Ding W; Cao C; Wu P; Li L
    Aging (Albany NY); 2024 Jan; 16(1):568-592. PubMed ID: 38206304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cervical squamous cell carcinoma feature genes and construction of a prognostic model based on immune-related features.
    He C; Ren L; Yuan M; Liu M; Liu K; Qian X; Lu J
    BMC Womens Health; 2022 Sep; 22(1):365. PubMed ID: 36057587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma.
    Lin S; Sun Y; Cao C; Zhu Z; Xu Y; Liu B; Hu B; Peng T; Zhi W; Xu M; Ding W; Ren F; Ma D; Li G; Wu P
    EBioMedicine; 2023 Nov; 97():104846. PubMed ID: 37879219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Analysis of Mutation Status and Immune Landscape for Squamous Cell Carcinomas at Different Anatomical sites.
    Ti W; Wei T; Wang J; Cheng Y
    Front Immunol; 2022; 13():947712. PubMed ID: 35935970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic genes in the tumor microenvironment in cervical squamous cell carcinoma.
    Pan XB; Lu Y; Huang JL; Long Y; Yao DS
    Aging (Albany NY); 2019 Nov; 11(22):10154-10166. PubMed ID: 31740624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.
    Peng G; Dan W; Jun W; Junjun Y; Tong R; Baoli Z; Yang X
    Tumour Biol; 2015 May; 36(5):3309-17. PubMed ID: 25586346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix.
    Salarzaei M; van de Laar RLO; Ewing-Graham PC; Najjary S; van Esch E; van Beekhuizen HJ; Mustafa DAM
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed proteins among normal cervix, cervical intraepithelial neoplasia and cervical squamous cell carcinoma.
    Zhao Q; He Y; Wang XL; Zhang YX; Wu YM
    Clin Transl Oncol; 2015 Aug; 17(8):620-31. PubMed ID: 25893434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional enrichment analysis of LYSET and identification of related hub gene signatures as novel biomarkers to predict prognosis and immune infiltration status of clear cell renal cell carcinoma.
    Chen Y; He J; Jin T; Zhang Y; Ou Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16905-16929. PubMed ID: 37740762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of seven immune-related genes can serve as a good predictive biomarker for cervical squamous cell carcinoma.
    Dai J; Pan Y; Chen Y; Yao S
    Front Genet; 2022; 13():1024508. PubMed ID: 36406134
    [No Abstract]   [Full Text] [Related]  

  • 13. Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell Carcinoma.
    Liu H; Xu R; Gao C; Zhu T; Liu L; Yang Y; Zeng H; Huang Y; Wang H
    Front Oncol; 2021; 11():755668. PubMed ID: 34733790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
    Qin R; Cao L; Ye C; Wang J; Sun Z
    BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key immune cell-related genes involved in tumorigenesis and prognosis of cervical squamous cell carcinoma.
    Yan C; Ma Y; Li J; Chen X; Ma J
    Hum Vaccin Immunother; 2023 Aug; 19(2):2254239. PubMed ID: 37799074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell sequencing highlights heterogeneity and malignant progression in actinic keratosis and cutaneous squamous cell carcinoma.
    Zou DD; Sun YZ; Li XJ; Wu WJ; Xu D; He YT; Qi J; Tu Y; Tang Y; Tu YH; Wang XL; Li X; Lu FY; Huang L; Long H; He L; Li X
    Elife; 2023 Dec; 12():. PubMed ID: 38099574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of Key Genes Combining with Immune Infiltration Level andTumor Mutational Burden in Hepatocellular Carcinoma.
    Chen J; Zhang L; Lu CH; Xu CZ
    Comb Chem High Throughput Screen; 2024; 27(14):2110-2124. PubMed ID: 38213141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-Based Classification of Cervical Squamous Cell Carcinoma into Two New Subclasses Differing in Immune-Related Gene Expression.
    Li X; Cai Y
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30445744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of BRCA1 on the Concurrent Chemoradiotherapy Resistance of Cervical Squamous Cell Carcinoma Based on Transcriptome Sequencing Analysis.
    Wen X; Liu S; Cui M
    Biomed Res Int; 2020; 2020():3598417. PubMed ID: 32685473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.